Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NACAH: NAC for infection risk in alcoholic hepatitis
NCT03069300Phase 3Unknown
- Sponsor
- Imperial College London
- Start
- Oct 2015
- Primary completion
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of acetylcysteine in alcoholic hepatitis (AH), sponsored by Imperial College London. Status: unknown.
02
Drugs
acetylcysteine
03
Conditions
alcoholic hepatitis (AH)
Beyond the preview
Go deeper on NCT03069300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03069300.